The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.
NCT ID: NCT01891435
Last Updated: 2013-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
434 participants
INTERVENTIONAL
2010-01-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in the Treatment of Fever Due to Upper Respiratory Tract Infection
NCT03918135
Treatment Of Fever In The Emergency Department
NCT05814302
Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache
NCT04372264
Paracetamol as Antipyretic and Analgesic Medication
NCT01070732
Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children
NCT02294071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral paracetamol
patients in this arm will receive 1000mg of oral paracetamol
Oral paracetamol
after giving medicine temperature is checked every 30 minutes for 2 hours
Intravenous paracetamol
patients in this arm will receive 1000 mg of intravenous paracetamol
Intravenous paracetamol
after giving medicine temperature is checked every 30 minutes for 2 hours
Intramuscular Diclofenac
patients in this arm will receive 75 mg of intramuscular diclofenac sodium
Intramuscular diclofenac
after giving medicine temperature is checked every 30 minutes for 2 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral paracetamol
after giving medicine temperature is checked every 30 minutes for 2 hours
Intravenous paracetamol
after giving medicine temperature is checked every 30 minutes for 2 hours
Intramuscular diclofenac
after giving medicine temperature is checked every 30 minutes for 2 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Had taken antipyretics within 8 hours
* Renal, hepatic or haematological disorders
* bronchial asthma, peptic ulcer disease, vomiting
* Pregnant or lactating women
14 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamad Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Firjeeth C Paramba
Specialist, Emergency Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
osama H Mohammed
Role: PRINCIPAL_INVESTIGATOR
Hamad Medical Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamad medical corporation
Doha, , Qatar
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9070/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.